These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
292 related articles for article (PubMed ID: 8386304)
21. Evidence for the involvement of a small subregion of the endoplasmic reticulum in the inositol trisphosphate receptor-induced activation of Ca2+ inflow in rat hepatocytes. Gregory RB; Wilcox RA; Berven LA; van Straten NC; van der Marel GA; van Boom JH; Barritt GJ Biochem J; 1999 Jul; 341 ( Pt 2)(Pt 2):401-8. PubMed ID: 10393099 [TBL] [Abstract][Full Text] [Related]
22. Synthesis and application of photoaffinity analogues of inositol 1,4,5-trisphosphate selectively substituted at the 1-phosphate group. Schäfer R; Nehls-Sahabandu M; Grabowsky B; Dehlinger-Kremer M; Schulz I; Mayr GW Biochem J; 1990 Dec; 272(3):817-25. PubMed ID: 2176480 [TBL] [Abstract][Full Text] [Related]
23. Comparative studies of D-myoinositol 1,4,5-trisphosphate and synthetic 6-deoxy D-myoinositol 1,4,5-trisphosphate: binding and calcium release activity in rat parotid microsomes. Bonis D; Sezan A; Mauduit P; Dubreuil D; Cleophax J; Gero SD; Rossignol B Biochem Biophys Res Commun; 1991 Mar; 175(3):894-900. PubMed ID: 1850995 [TBL] [Abstract][Full Text] [Related]
24. 3-position modification of myo-inositol 1,4,5-trisphosphate: consequences for intracellular Ca2+ mobilisation and enzyme recognition. Safrany ST; Wilcox RA; Liu C; Potter BV; Nahorski SR Eur J Pharmacol; 1992 Jul; 226(3):265-72. PubMed ID: 1330634 [TBL] [Abstract][Full Text] [Related]
25. Dimers of D-myo-inositol 1,4,5-trisphosphate: design, synthesis, and interaction with Ins(1,4,5)P3 receptors. Riley AM; Laude AJ; Taylor CW; Potter BV Bioconjug Chem; 2004; 15(2):278-89. PubMed ID: 15025523 [TBL] [Abstract][Full Text] [Related]
26. Ca2(+)-mobilising properties of synthetic fluoro-analogues of myo-inositol 1,4,5-trisphosphate and their interaction with myo-inositol 1,4,5-trisphosphate 3-kinase and 5-phosphatase. Safrany ST; Sawyer D; Wojcikiewicz RJ; Nahorski SR; Potter BV FEBS Lett; 1990 Dec; 276(1-2):91-4. PubMed ID: 2176165 [TBL] [Abstract][Full Text] [Related]
27. Synthesis, calcium mobilizing, and physicochemical properties of D-chiro-inositol 1,3,4,6-tetrakisphosphate, a novel and potent ligand at the D-myo-inositol 1,4,5-trisphosphate receptor. Liu C; Davis RJ; Nahorski SR; Ballereau S; Spiess B; Potter BV J Med Chem; 1999 Jun; 42(11):1991-8. PubMed ID: 10354407 [TBL] [Abstract][Full Text] [Related]
28. Heterogeneity of [3H]inositol 1,4,5-trisphosphate binding sites in adrenal-cortical membranes. Characterization and validation of a radioreceptor assay. Challiss RA; Chilvers ER; Willcocks AL; Nahorski SR Biochem J; 1990 Jan; 265(2):421-7. PubMed ID: 2154189 [TBL] [Abstract][Full Text] [Related]
29. A saturable receptor for 32P-inositol-1,4,5-triphosphate in hepatocytes and neutrophils. Spät A; Bradford PG; McKinney JS; Rubin RP; Putney JW Nature; 1986 Feb 6-12; 319(6053):514-6. PubMed ID: 3003582 [TBL] [Abstract][Full Text] [Related]
30. Structural analogues of D-myo-inositol-1,4,5-trisphosphate and adenophostin A: recognition by cerebellar and platelet inositol-1,4,5-trisphosphate receptors. Murphy CT; Riley AM; Lindley CJ; Jenkins DJ; Westwick J; Potter BV Mol Pharmacol; 1997 Oct; 52(4):741-8. PubMed ID: 9380038 [TBL] [Abstract][Full Text] [Related]
31. Heterologous desensitization of both phosphoinositide and Ca2+ signaling in SH-SY5Y neuroblastoma cells: a role for intracellular Ca2+ store depletion? Willars GB; Nahorski SR Mol Pharmacol; 1995 Mar; 47(3):509-16. PubMed ID: 7700249 [TBL] [Abstract][Full Text] [Related]
32. Binding and activity of the nine possible regioisomers of myo-inositol tetrakisphosphate at the inositol 1,4,5-trisphosphate receptor. Burford NT; Nahorski SR; Chung SK; Chang YT; Wilcox RA Cell Calcium; 1997 Apr; 21(4):301-10. PubMed ID: 9160166 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of inositol 1,4,5-trisphosphate metabolism in permeabilised SH-SY5Y human neuroblastoma cells by a phosphorothioate-containing analogue of inositol 1,4,5-trisphosphate. Wojcikiewicz RJ; Cooke AM; Potter BV; Nahorski SR Eur J Biochem; 1990 Sep; 192(2):459-67. PubMed ID: 2209601 [TBL] [Abstract][Full Text] [Related]
34. DL-myo-inositol 1,2,4,5-tetrakisphosphate, a potent analog of D-myo-inositol 1,4,5-trisphosphate. Hirata M; Narumoto N; Watanabe Y; Kanematsu T; Koga T; Ozaki S Mol Pharmacol; 1994 Feb; 45(2):271-6. PubMed ID: 8114676 [TBL] [Abstract][Full Text] [Related]
35. Stereospecific mobilization of intracellular Ca2+ by inositol 1,4,5-triphosphate. Comparison with inositol 1,4,5-trisphosphorothioate and inositol 1,3,4-trisphosphate. Strupish J; Cooke AM; Potter BV; Gigg R; Nahorski SR Biochem J; 1988 Aug; 253(3):901-5. PubMed ID: 3263119 [TBL] [Abstract][Full Text] [Related]
36. Inositol tetrakisphosphate mobilizes calcium from cerebellum microsomes. Joseph SK; Hansen CA; Williamson JR Mol Pharmacol; 1989 Sep; 36(3):391-7. PubMed ID: 2550775 [TBL] [Abstract][Full Text] [Related]
38. D-myo-inositol 1,4,5-trisphosphate analogues modified at the 3-position inhibit phosphatidylinositol 3-kinase. Ward SG; Mills SJ; Liu C; Westwick J; Potter BV J Biol Chem; 1995 May; 270(20):12075-84. PubMed ID: 7744856 [TBL] [Abstract][Full Text] [Related]
39. Are there subtypes of the inositol 1,4,5-trisphosphate receptor? Varney MA; Rivera J; Lopez Bernal A; Watson SP Biochem J; 1990 Jul; 269(1):211-6. PubMed ID: 2165396 [TBL] [Abstract][Full Text] [Related]
40. Roles for hydroxyl groups of D-myo-inositol 1,4,5-trisphosphate in the recognition by its receptor and metabolic enzymes. Hirata M; Watanabe Y; Yoshida M; Koga T; Ozaki S J Biol Chem; 1993 Sep; 268(26):19260-6. PubMed ID: 8396130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]